Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My take on all this (IMO)
PR dated 11/11/2004:

and related royalty-sharing scheme

It's exactly what we/they have now

2005-06-07
Patriot Scientific and TPL Group Unify Portfolio of Fundamental Microprocessor Patents

2005-06-15
Patriot Scientific Names New Chairman/CEO David H. Pohl to Lead Company in New Direction

Wallin was responsible for denying/delaying an earlier merger of the MMP ownership (by ~ 3 yrs). And IMO therefore prevented us from currently being deep into licensing the MMP for big bucks.. As I have posted before, our OS would would be substantially less, Swartz would have had significantly fewer warrants/shares to unload, PTO would be behind us already, and we would not have had to deal with 'Patent Reform' at such a critical time.

Everybody seems to think TPL offered us $7.5M and nothing else... When it very may have been $7.5M and 50% royalty sharing, as we have... and if it wasn't 50%, it more than likely would have been with any modicum of negotiation.

jmo

Share
New Message
Please login to post a reply